Baxter International announces the continued expansion of its pharmaceuticals portfolio with new injectable product launches in the US. Ropivacaine hydrochloride injection, USP is available in a ready-to-use, single-dose infusion bag. Indicated in adults to produce local or regional anesthesia for surgery and for acute pain management, ropivacaine is offered in 200 mg/100 mL and 400 mg/200 mL strengths. Regadenoson injection pre-filled syringe, a coronary vasodilator that is commonly used in pharmacologic stress testing, is offered in a 0.4 mg/5 mL strength.